Zacks Investment Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-21,603	Closed	-$861K	–	658
2017 Q2	$861K	Buy	21,603 +959	+5%	+$38.2K	0.02%	401
2017 Q1	$760K	Buy	20,644 +8,396	+69%	+$309K	0.02%	411
2016 Q4	$390K	Buy	12,248 +5,583	+84%	+$178K	0.01%	471
2016 Q3	$242K	Buy	+6,665	New	+$242K	0.01%	531